A B S T R A C T Others have observed that dopamine (3,4-dihydroxyphenylethylamine) constricts resistance vessels in skin, but dilates these vessels in the mesentery. We studied the effects of dopamine on cutaneous and mesenteric veins of dogs to see if this agent also produced qualitatively different effects on the tone of capacitance vessels (veins) in these vascular beds. The lateral saphenous or the left colic vein was perfused at constant flow with blood from a femoral artery. Pressures at the tip of the perfusion cannula and at the tip of a catheter 15 cm downstream were recorded continuously. Increases in the pressure gradient between these two points indicated venoconstriction; decreases indicated venodilatation. Dopamine and norepinephrine injected into the perfusion tubing caused constriction of both veins. The constriction was antagonized by blockade of alpha receptors. A dilator action of dopamine was not seen, even after alpha receptor blockade or in the presence of increased venous tone produced by serotonin, norepinephrine, or nerve stimulation. Reserpine and cocaine did not alter responses to dopamine in the saphenous vein; this suggests that the venoconstrictor action of dopamine results mainly from a direct effect on alpha receptors and that uptake into sympathetic nerve endings may not be important in regulating the amount of dopamine available to receptors in the saphenous vein.
INTRODUCTION
Few if any stimuli produce qualitatively different effects on tone of capacitance vessels (veins) in different vascular beds. We considered the possibility that dopamine might be an exception since its effects on resistance vessels differ in the limb and the mesentery (1, 2) . If The experiments reported here were done to study the actions of dopamine on the lateral saphenous and the left colic veins of dogs.
METHODS
Methods. Dogs weighing 17-26 kg were anesthetized with chloralose (75 mg/kg) and urethane (500 mg/kg). An endotracheal tube was inserted and the dogs were given decamethonium bromide (0.3 mg/kg) intravenously and ventilated. Heparin sodium (500 U/kg) was given intravenously when the operative procedures were completed.
We measured responses of the lateral saphenous vein using a modification of the method described recently by Webb-Peploe and Shepherd (3) . The dorsal branch of the left lateral saphenoug vein was cannulated at the ankle and perfused at constant flow, 56-72 ml/min, with blood from the right femoral artery using a Harvard peristaltic pump.
The two major tributaries, the plantar branch and the calcaneal branch, were ligated and a small polyethylene catheter was inserted through one of these into the lateral saphenous vein so that the tip was 15 cm downstream from the perfusion cannula. Pressure at the tip of the perfusion cannula (perfusion pressure) . . , m -r l .
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EXP. 0.1-0.4 ml; injection of these volumes of dextrose solution alone had no effect. Other drugs used in some of these experiments were phentolamine mesylate, phenoxybenzamine hydrochloride, cocaine hydrochloride, and reserpine.
Design. The plan of this study was first, to see if dopamine caused constriction or dilatation of saphenous and colic veins; second, to determine if a dilator response to dopamine could be unmasked by blocking the constrictor response; third, to see if dopamine exerted an indirect as well as direct sympathomimetic effect on the saphenous vein by studying responses after reserpine; fourth, by using cocaine to see if uptake of dopamine into sympathetic nerve endings was an important factor regulating the availability of dopamine to receptor sites in the saphenous vein; and fifth, to establish the relative venoconstrictor potency of dopamine and norepinephrine.
Initially we studied saphenous responses in eight dogs. In each experiment, four doses of dopamine (60, 120, 240, and 480 jsg) and four doses of norepinephrine (3, 6, 12 , and 24 gg) were given at 5-to 7-min intervals at a time when pressures had returned to control levels. A modified Latin square determined the order of administration. After these injections, serotonin (30 jsg) was given as an internal control. To study the effect of alpha receptor blockade, we then gave phenoxybenzamine (7.5 (Table I) indicated that the relative potency (R.P.) of dopamine compared with norepinephrine in the saphenous vein was 12.6 (95% confidence limits 9.7-16.5). The relative potency indicates the ratio of the dose of dopamine required to produce a given response to the dose of norepinephrine required to produce the same response. The relative potency of dopamine to norepinephrine in the colic vein was 24.5 (95% confidence limits 19.1-32.0) (Table II) .
Similar studies were done on the colic vein in six other dogs. The three highest doses of dopamine and norepinephrine were given, and phentolamine (3-4 mg) was used as the alpha receptor antagonist.
In other experiments on the saphenous or the colic vein, dopamine, isoproterenol, and nitroglycerin were administered in the presence of increased venous tone produced by serotonin, norepinephrine, or nerve stimulation.
Finally, the effects of reserpine and cocaine on saphenous vein responses were studied in 12 dogs divided into two equal groups. One group received reserpine (0.25 mg/kg intraperitoneally) 24 and 48 hr before study; the other group was not treated with reserpine. In each experiment, responses to tyramine (500 and 1000 /Ag), dopamine (30 and 120 lsg), and norepinephrine (1.5 and 6.0 Ag) were obtained before and after cocaine (6-10 mg) was administered into the perfusion tubing.
Statistical comparisons were made using analysis of variance and, in appropriate instances, the parallel line bioassay (4, 5) . Responses to the various agents were taken as peak changes in the pressure gradient.
RESULTS
Saphenous vein responses to dopamine, norepineph- (Fig. 3) .
Effects of reserpine and cocaine 'on responses of saphenous vein. Responses of the reserpinized group were compared with those of the group not pretreated.
Reserpine virtually abolished the constriction with tyramine, but did not alter significantly responses to dopamine and norepinephrine (Fig. 4) .
In the nonreserpinized dogs, a dose of cocaine which reduced responses to tyramine also potentiated responses (D) or norepinephrine (NE) before cocaine were compared with responses after cocaine using pafallel line bioassay. This was done by regarding injections of dopamine or norepinephrine before cocaine as standard preparations and injections after cocaine as test preparations. R.P. represents the relative potency with 95% confidence limits; this indicates the ratio of the dose required to produce a given response before cocaine to the dose required to produce the same response after cocaine. The effect of either agent was considered to be significantly tgreater after cocaine if a potency ratio of 1.0 was not included in the confidence limits.
to norepinephrine, but did not significantly change responses to dopamine (Fig. 5, top panels) . Cocaine also potentiated the constrictor responses to norepinephrine in the reserpinized group, but again did not alter responses to dopamine (Fig. 5, bottom panels) .
Colic vein responses to dopamine and norepinephrine. Both dopamine and norepinephrine caused constriction of the colic vein. Increases in the pressure gradient with the three doses of dopamine (120, 240, and 480 tg) averaged 4.0 ±0.8 (SEM), 7.1 +1.6, and 13.0 ±1.7 mm Hg, respectively (Fig. 2) . Corresponding increases with norepinephrine (6, 12, and 24 /Ag) were 5.3 +1.6, 9.0 ±2.1, and 13.6 ±1.3 mm Hg (Fig. 2) . Parallel line bioassay indicated that the dose of dopamine required to produce a given response was 24.5 times the dose of norepinephrine needed to produce the same response ( Fig. 2 and Table II) (4, 5) .
In eight experiments dopamine was administered in the presence of increased venous tone induced by seroVenomotor Response to Dopamine 263 5C (Fig. 4) . Other investigators demonstrated both direct and indirect sympathomimetic effects of dopamine on the cat nictitating membrane (7, 8) and the guinea pig atria (7) but GuimarAes and Osswald (9) reported recently that reserpine does not influence the responses of strips of lateral saphenous vein to dopamine.
It may be noted also that reserpine did not augment the venoconstriction with norepinephrine. This is consistent with an earlier report by Abboud and Eckstein that the veins do not participate in the increased vascular responsiveness to norepinephrine occurring after reserpine (10) .
Administration of cocaine potentiated the responses to norepinephrine, but did not potentiate the constriction with dopamine, even in dogs treated with reserpine. Considerable evidence supports the view that cocaine causes supersensitivity to 1-norepinephrine by preventing uptake into nerve endings so that more amine becomes available to the receptor site (11) . The results of these experiments suggest, therefore, that uptake into sympathetic nerve endings may not be important in regulating the concentration of dopamine at receptor sites in the lateral saphenous vein. In contrast, these and other experiments (12) support the view that uptake into nerve endings is an important factor regulating the amount of norepinephrine available to receptors in the saphenous vein.
Responses to all of the agonists used in these studiies were greater in the saphenous than in the colic vein. These differences may result from differences in vessel geometry. Because of this reservation, a statistical analysis comparing responses of the two veins to a given agent was not made. The relative potencies which are cited in Fig. 2 compare responses to two agents, dopamine and norepinephrine, in a single vein. In both the saphenous and the colic veins, more dopamine than norepinephrine was needed to produce a given venoconstrictor response. Specifically, the ratio of the dose of dopamine to the dose of norepinephrine needed to cause a given response was 12.6 in the saphenous vein and 24.5 in the colic vein. These ratios are lower than those reported by investigators studying the effects of dopamine and norepinephrine on resistance vessels in the limb (1), the rabbit aorta (13) , and the dog heart (14) . For instance, McNay et al. demonstrated that the dose of dopamine causing a given decrease in femoral blood flow was 44 times the dose of norepinephrine causing the same response (1). Kohli found a similar ratio in the rabbit aorta where 50 times more dopamine than norepinephrine was needed to produce a given level of alpha receptor stimulation (13) . In the dog heart-lung preparation Holmes and Fowler observed that 100 times more dopamine than norepinephrine was needed to produce comparable cardiac responses (14) . The difference in the relative potency of the two drugs on the veins and the heart probably results from the fact that alpha receptors mediate the responses in the veins and beta receptors in the heart. The reasons for the difference in relative potency on arteries and veins are not clear. Whatever the reasons, these observations suggest that when compared to norepinephrine the venoconstrictor action of dopamine is greater than its effects on the heart and on resistance vessels in the limb. This relatively greater venoconstrictor action may be important since dopamine is used to treat patients with hypotension and shock; the venoconstriction would tend to increase venous return and cardiac filling pressure.
